HAP Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,960
| Closed | -$50K | – | 1399 |
|
|
2022
Q4 | $50K | Sell |
18,960
-6,500
| -26% | -$217K | 0.01% | 736 |
|
|
2022
Q3 | $142K | Buy |
25,460
+9,940
| +64% | +$377K | 0.01% | 706 |
|
|
2022
Q2 | $29K | Sell |
15,520
-43,760
| -74% | -$2.42M | ﹤0.01% | 1231 |
|
|
2022
Q1 | $38K | Buy |
59,280
+33,760
| +132% | +$1.83M | ﹤0.01% | 1345 |
|
|
2021
Q4 | $26K | Sell |
25,520
-1,680
| -6% | -$87.4K | ﹤0.01% | 1717 |
|
|
2021
Q3 | $85K | Sell |
27,200
-5,360
| -16% | -$269K | ﹤0.01% | 1315 |
|
|
2021
Q2 | $64K | Sell |
32,560
-5,840
| -15% | -$281K | ﹤0.01% | 1381 |
|
|
2021
Q1 | $134K | Buy |
38,400
+6,720
| +21% | +$305K | 0.01% | 866 |
|
|
2020
Q4 | $135K | Buy |
31,680
+22,720
| +254% | +$1.04M | ﹤0.01% | 1074 |
|
|
2020
Q3 | $44K | Hold |
8,960
| – | – | ﹤0.01% | 999 |
|
|
2020
Q2 | $35K | Sell |
8,960
-9,760
| -52% | -$501K | ﹤0.01% | 1153 |
|
|
2020
Q1 | $169K | Buy |
+18,720
| New | +$999K | 0.01% | 571 |
|
|
2019
Q4 | – | Sell |
-14,320
| Closed | -$10K | – | 1327 |
|
|
2019
Q3 | $10K | Buy |
+14,320
| New | +$737K | ﹤0.01% | 1050 |
|
|
2019
Q2 | – | Sell |
-13,680
| Closed | -$12K | – | 1214 |
|
|
2019
Q1 | $12K | Buy |
13,680
+3,760
| +38% | +$188K | ﹤0.01% | 905 |
|
|
2018
Q4 | $26K | Sell |
9,920
-7,920
| -44% | -$390K | ﹤0.01% | 835 |
|
|
2018
Q3 | $38K | Buy |
+17,840
| New | +$906K | ﹤0.01% | 666 |
|
|
2018
Q2 | – | Sell |
-8,000
| Closed | -$2K | – | 1042 |
|
|
2018
Q1 | $2K | Sell |
8,000
-27,920
| -78% | -$1.3M | ﹤0.01% | 881 |
|
|
2017
Q4 | $22K | Buy |
35,920
+2,080
| +6% | +$96.1K | ﹤0.01% | 773 |
|
|
2017
Q3 | $5K | Sell |
33,840
-13,920
| -29% | -$706K | ﹤0.01% | 834 |
|
|
2017
Q2 | $12K | Sell |
47,760
-7,520
| -14% | -$401K | ﹤0.01% | 832 |
|
|
2017
Q1 | $40K | Sell |
55,280
-21,440
| -28% | -$1.09M | ﹤0.01% | 718 |
|
|
2016
Q4 | $158K | Sell |
76,720
-20,960
| -21% | -$1.04M | 0.01% | 499 |
|
|
2016
Q3 | $110K | Sell |
97,680
-45,520
| -32% | -$2.5M | ﹤0.01% | 583 |
|
|
2016
Q2 | $233K | Buy |
+143,200
| New | +$7.54M | 0.01% | 415 |
|
|
2016
Q1 | – | Sell |
-521,840
| Closed | -$65K | – | 895 |
|
|
2015
Q4 | $65K | Buy |
+521,840
| New | +$26.6M | ﹤0.01% | 609 |
|
|
2015
Q3 | – | Sell |
-12,560
| Closed | -$41K | – | 1099 |
|
|
2015
Q2 | $41K | Sell |
12,560
-2,240
| -15% | -$126K | ﹤0.01% | 691 |
|
|
2015
Q1 | $40K | Sell |
14,800
-80
| -0.5% | -$4.59K | ﹤0.01% | 643 |
|
|
2014
Q4 | $67K | Buy |
+14,880
| New | +$832K | ﹤0.01% | 686 |
|
Other funds holding GSK
JEST
HAP Trading's GSK Position: Q1 2023 in Review
HAP Trading sold out of GSK (GSK) in Q1 2023, closing a stake of 33,080 shares — an estimated $1.16M sold.
HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $4.42M in Q4 2015. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.
- HAP Trading reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
- HAP Trading sold 33,080 GSK shares in Q1 2023, an estimated $1.16M.
- HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters.
- HAP Trading's GSK position peaked at $4.42M in Q4 2015.
- 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.
Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.